• OPEN AN ACCOUNT
Indian Indices
Sensex
78,744.40 1,443.00
( 1.87%)
Global Indices
Nasdaq
53,347.89 1,540.17
(2.97%)
Dow Jones
7,717.41 127.49
(1.68%)
Hang Seng
62,088.48 -993.38
(-1.57%)
Nikkei 225
10,852.07 213.64
(2.01%)
Forex
USD-INR
94.73 -0.07
(-0.07%)
EUR-INR
105.99 -0.12
(-0.11%)
GBP-INR
127.06 -0.04
(-0.03%)
JPY-INR
0.60 0.00
(-0.31%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
42.18
81.05
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

sanwaria consumer ltd
Ultracab (India) standalone net profit declines 44.35% in the March 2026 quarter
May 20,2026
Net profit of Ultracab (India) declined 44.35% to Rs 1.33 crore in the quarter ended March 2026 as against Rs 2.39 crore during the previous quarter ended March 2025. Sales rose 9.53% to Rs 79.90 crore in the quarter ended March 2026 as against Rs 72.95 crore during the previous quarter ended March 2025.

For the full year,net profit declined 42.49% to Rs 5.59 crore in the year ended March 2026 as against Rs 9.72 crore during the previous year ended March 2025. Sales rose 8.63% to Rs 260.10 crore in the year ended March 2026 as against Rs 239.43 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales79.9072.95 10 260.10239.43 9
OPM %3.276.85 -4.528.12 -
PBDT1.893.99 -53 9.0214.94 -40
PBT1.483.67 -60 7.4513.74 -46
NP1.332.39 -44 5.599.72 -42